NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for ABL-GROUP


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
ABL is Pleased to Announce the TherapyEdge ViroScore Suite Platform is Now Available in Brazil
2009 NOV 23 -- Advanced Biological Laboratories (ABL) and Centro de Genomas are pleased to announce an agency agreement whereby Centro de Genomas will provide to the private and public sectors throughout Brazil, the ABL TherapyEdge products in Portuguese......
Subject: ABL GROUP
Price: $3.00
*
American Biltrite Reports Third Quarter Results
2009 NOV 25 -- American Biltrite Inc. (NYSE Amex: ABL) reported its results for the third quarter of 2009 today. Net sales for the three months ended September 30, 2009 were $83.9 million, down 13.8% from $97.4 million in the third quarter of 2008. The net loss......
Subject: American Biltrite Inc.
Price: $3.00
*
American Biotech Labs Receives FDA Clearance for New Prescription Wound Dressing Gel
2009 NOV 30 -- American Biotech Labs, LLC (ABL), developer of a new class of products based on the company's patented nano-catalytic SilverSol Technology®, announced that the company has obtained clearance by the U.S. Food and Drug Administration (FDA) to......
Subject: American Biotech Labs, Llc
Price: $3.00
*
ChemGenex Announces FDA Accepts NDA for Omapro(TM) Omacetaxine Mepesuccinate and Grants the Filing Priority Review Status
2009 NOV 23 -- ChemGenex Pharmaceuticals Limited (ASX:CXS) announced that the U.S. Food & Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for Omapro™ (omacetaxine mepesuccinate) for the treatment of patients with chronic......
Subject: ChemGenex Pharmaceuticals Limited
Price: $3.00
*
Data on myelocytic leukemia discussed by researchers at Istanbul University, Medical Department
2009 NOV 23 -- "We aimed to compare the cytogenetic and molecular analyses in the assessment of imatinib mesylate response in patients suffering the chronic phase of chronic myelocytic leukemia who were refractory to a-interferon treatment. A total of 117......
Subject: Myelocytic Leukemia
Price: $3.00
*
FirstMerit to Acquire 24 Chicago-Area Branches and the Midwest Asset Based Loan Business From First Bank
2009 NOV 25 -- FirstMerit Corporation (NASDAQ:FMER) has signed a definitive purchase and assumption (P&A) agreement to acquire approximately $1.2 billion of deposits and 24 Chicago-area branches from St. Louis, Mo.-based First Bank. FirstMerit will also acquire......
Subject: FirstMerit Corporation
Price: $3.00
*
MultiVu Video Feed: BASKETBALL LEGEND KAREEM ABDUL-JABBAR ANNOUNCES HE HAS BEEN DIAGNOSED WITH
2009 NOV 23 -- Kareem Abdul-Jabbar, one of the greatest basketball players of all time, known for his unblockable signature "sky hook" shot, has announced that he was diagnosed late last year with a rare type of blood cancer known as Philadelphia......
Subject: Cancer
Price: $3.00
*
New transplantation study findings reported from University of Louisville
2009 NOV 23 -- According to recent research published in the journal Transplantation, "Mixed chimerism induces donor-specific tolerance to composite tissue allotransplants (CTAs). In the present studies, we used a nonmyeloablative conditioning approach to......
Subject: Transplantation
Price: $3.00
*
Research by V.G. Oehler and colleagues in leukemia provides new insights
2009 NOV 23 -- According to recent research from the United States, "The preferentially expressed antigen in melanoma (PRAME) is expressed in several hematologic malignancies, but either is not expressed or is expressed at only low levels in normal......
Subject: Leukemia
Price: $3.00
*
Research conducted at Henry Ford Hospital has updated our knowledge about tics
2009 NOV 30 -- According to recent research from the United States, "The presence of the JAK2 V617F mutation is now part of clinical diagnostic algorithms, and JAK2 status is routinely assessed when BCR/ABL-chronic myeloproliferative neoplasms (MPNs) are......
Subject: Tics
Price: $3.00
*
Research conducted at Pennsylvania State University has provided new information about proteome research
2009 NOV 23 -- According to recent research from the United States, "Mitochondria, the powerhouse of eukaryotic cells, have their own translation machinery that is solely responsible for synthesis of 13 mitochondrially encoded protein subunits of oxidative......
Subject: Proteome Research
Price: $3.00
*
Research from S. Cooper and co-authors reveals new findings on leukemia therapy
2009 NOV 23 -- Current study results from the report, 'Overcoming resistance in chronic myelogenous leukemia,' have been published. "Chronic myeloid leukemia is defined by the acquired genetic mutation, t(9;22), which leads to the fusion-protein BCR-ABL.......
Subject: Leukemia Therapy
Price: $3.00
*
Researchers at Yale University target life sciences
2009 NOV 23 -- "Adolescence is characterized by increased vulnerability to developing neuropsychiatric disorders and involves a period of prefrontal cortical dendritic refinement and synaptic pruning that culminates in cytoskeletal stabilization in adulthood.......
Subject: Life Sciences
Price: $3.00
*
Studies from Tor Vergata University further understanding of chemotherapy
2009 NOV 23 -- "Germ cells are sensitive to genotoxins, and ovarian failure and infertility are major side effects of chemotherapy in young patients with cancer. Here we describe the c-Abl-TAp63 pathway activated by chemotherapeutic DNA-damaging drugs in model......
Subject: Chemotherapy
Price: $3.00
*
Studies from Vrije University Amsterdam further understanding of hematology
2009 NOV 23 -- "A 51-year-old male was diagnosed with chronic phase chronic myeloid leukemia (CML) in May 2005. His Sokal score at diagnosis was 0.95 and his Euro score was 1,363 (both intermediate risk)," investigators in Netherlands report.   ......
Subject: Hematology
Price: $3.00
*
United Rentals Announces Aggregate $550 Million in Senior Notes Offerings
2009 NOV 25 -- United Rentals, Inc. (NYSE: URI) ("URI") announced that it is offering $150 million ($172.5 million if the underwriters' over-allotment option is exercised in full) principal amount of convertible senior unsecured notes due 2015, and its......
Subject: United Rentals, Inc.
Price: $3.00
*
United Rentals Announces Pricing of Aggregate $650 Million of Senior Notes
2009 NOV 25 -- United Rentals, Inc. (NYSE: URI) ("URI") announced that it has priced an offering of $150 million principal amount of 4.00% convertible senior unsecured notes due 2015, and its subsidiary, United Rentals (North America), Inc. ("URNA") has......
Subject: United Rentals, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login